At the workshop, experts will review evidence on the potential benefits of probiotics and other products containing live bacteria to help treat certain medical conditions, such as neonatal necrotizing enterocolitis.
While there is growing interest within the healthcare industry about the use of probiotics, some health experts said they feel more research is required to ensure the products’ safety and efficacy.
Pieter Cohen, MD, assistant professor at Boston-based Harvard Medical School who studies supplements, told STAT he hopes “the FDA will focus on how to modernize its antiquated approach to ensuring probiotic safety and ensure that only high-quality products are available to consumers.”
More articles on clinical leadership and infection control:
Alaska psych hospital prioritizes patient safety over staff, employees say
‘Vampire facial’ puts New Mexico spa clients at risk of HIV, hepatitis
FDA proposes antibiotic subscription plan for hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
